Accessibility links
paxlovid paxlovid
Stories About

paxlovid

Tuesday

In a pandemic milestone, the NIH ends guidance on COVID treatment

Pfizer's Paxlovid combines two antiviral drugs to fight the virus that causes COVID-19. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Shots - Health News

In a pandemic milestone, the NIH ends guidance on COVID treatment

The National Institutes of Health is sunsetting its influential COVID-19 treatment guidelines, used by millions of doctors to guide care during the pandemic.

In a pandemic milestone, the NIH ends guidance on COVID treatment

Listen · 3:48
  • Download
  • <iframe src="https://www.npr.org/player/embed/1239276507/1239276923" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Thursday

Friday

Coronavirus FAQ: 'Emergency' over! Do we unmask and grin? Or adjust our worries?

A poster in Kolkata, India, from peak pandemic days sends a message to mask up. Now that the official COVID-19 global emergency is no longer in effect, some folks are thrilled to stop masking — but others wonder if it's a good idea to keep up certain precautions. NurPhoto via Getty Images hide caption

toggle caption
NurPhoto via Getty Images

Goats and Soda

Coronavirus FAQ: 'Emergency' over! Do we unmask and grin? Or adjust our worries?

Now that official COVID emergency declarations have ended, how should people evaluate their risk of SARS-CoV-2? That's the subject of our frequently asked questions offering.

Friday

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

Pfizer's Paxlovid pills are considered the most effective treatment to prevent severe COVID. They're about to be sold in China. But they are reportedly underused in the U.S. Joe Raedle/Getty Images hide caption

toggle caption
Joe Raedle/Getty Images

Goats and Soda

Coronavirus FAQ: Is Paxlovid the best treatment? Is it underused in the U.S.?

The drug is the most effective way to cut the risk of severe disease. It's heading to China now. Yet the drug is underused in some places. Why? And are there options if you're not a good candidate?

Sunday

Thursday

Wednesday

Tuesday

Biden will make Paxlovid, a highly effective COVID drug, available to more pharmacies

President Biden is seen delivering remarks on COVID-19 on March 30. On Tuesday, the White House will announce a new push to get more doses of the COVID antiviral medication Paxlovid to more Americans. Anna Moneymaker/Getty Images hide caption

toggle caption
Anna Moneymaker/Getty Images

Politics

Biden will make Paxlovid, a highly effective COVID drug, available to more pharmacies

The antiviral pill is available to patients older than 12 who have tested positive for COVID and are at risk for developing a severe case of the disease.

Friday

Lifesaving COVID drugs are sitting unused on pharmacy shelves, HHS data shows

Treatments like monoclonal antibody infusions and antiviral pills can prevent a case of COVID-19 from becoming life-threatening. But many of the available drugs are not being used. Emily Elconin/Bloomberg via Getty Images hide caption

toggle caption
Emily Elconin/Bloomberg via Getty Images

Shots - Health News

Lifesaving COVID drugs are sitting unused on pharmacy shelves, HHS data shows

States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste while people who could benefit get sicker.

Tuesday

'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited

A passer-by walks past a sign that calls attention to COVID-19 testing while departing a Walgreens pharmacy, Wednesday, Dec. 15, 2021, in New Bedford, Mass. (AP Photo/Steven Senne) Steven Senne/AP hide caption

toggle caption
Steven Senne/AP

Shots - Health News

'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited

The Biden administration's new program enables high-risk patients who test positive to get antiviral pills on the spot in some pharmacies. But many pharmacies won't be able to participate.

'Test to Treat' gets COVID pills to at-risk patients fast but its reach is limited

  • <iframe src="https://www.npr.org/player/embed/1085078893/1085187970" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">

Tuesday

Doctors find limited use for less effective COVID pill

Merck's anti-viral drug molnupiravir isn't popular with doctors who prefer to prescribe another antiviral, Paxlovid. Merck & Co Inc. hide caption

toggle caption
Merck & Co Inc.

Shots - Health News

Doctors find limited use for less effective COVID pill

The antiviral pill molnupiravir was authorized and distributed by the government late last year. But it's not doctors' first choice of treatment, except for a narrow slice of patients.

Doctors find limited use for less effective COVID pill

Listen · 3:52
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1081898013/1082401670" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Tuesday

Feds' contract with Pfizer for Paxlovid has some surprises

Paxlovid tablets are packaged at a Pfizer factory in Italy. Pfizer hide caption

toggle caption
Pfizer

Shots - Health News

Feds' contract with Pfizer for Paxlovid has some surprises

NPR has obtained the government's $5.3 billion contract for the first 10 million courses of Paxlovid, an antiviral pill for COVID-19. Here's what's in it.

Feds' contract with Pfizer for Paxlovid has some surprises

Listen · 4:02
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1075876794/1077371694" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Friday

The COVID antiviral drugs are here but they're scarce. Here's what to know
Thomas Hansmann/Pfizer

Shots - Health News

The COVID antiviral drugs are here but they're scarce. Here's what to know

Paxlovid and molnupiravir have been authorized for emergency use to keep COVID-19 patients out of the hospital, but don't expect to be able to go to your usual pharmacy and get them.

The COVID antiviral drugs are here but they're scarce. Here's what to know

Listen · 3:53
Transcript
  • Download
  • <iframe src="https://www.npr.org/player/embed/1069323181/1069739439" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Wednesday